Free Trial

Sarepta Therapeutics (SRPT) SEC Filings & 10K Form

Sarepta Therapeutics logo
$39.99 +2.05 (+5.40%)
Closing price 05/20/2025 04:00 PM Eastern
Extended Trading
$42.21 +2.22 (+5.56%)
As of 08:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sarepta Therapeutics SEC Filings

DateFilerForm TypeView
05/19/2025
6:32 AM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
6:00 AM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
3:15 PM
Sarepta Therapeutics (Filer)
Form ARS
03/13/2025
7:00 PM
Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:33 PM
Nicaise Claude (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
7:00 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:00 PM
Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM
Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM
Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM
Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
7:00 PM
Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:05 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
12:32 PM
Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:38 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM
Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
7:30 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
How to spot the exact time a stock tends to surge… or drop. (Ad)

Most folks have the idea of trading all wrong… And it honestly isn’t their fault. Look, we’ve seen the top traders at Wall Street pass on the narrative that you need to be a 100% savvy trader… or sit close to the charts all day just to target opportunities from the market… But in reality, you don’t need to do all that. In fact, according to a top trader who started using trading software before he could drive a car… studied technical analysis under two top minds in finance… And despite being 30 this year, he already has a decade of trading experience under his belt!

He says you could do it in a very straightforward way – just by knowing the exact time a stock is go
01/13/2025
11:25 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
7:00 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:06 PM
Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
7:00 PM
Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:18 PM
Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
7:15 PM
Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:00 PM
Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/26/2024
6:17 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:40 AM
JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
11/13/2024
9:27 AM
Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
09/16/2024
7:00 PM
Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2024
7:05 PM
Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:51 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:00 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
4:03 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:00 AM
Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:50 PM
Sarepta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2024
3:01 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
7:00 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM
Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:00 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:35 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
3:16 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:19 PM
Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
3:45 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SRPT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners